The new antipsychotics;Les nouveaux antipsychotiques

Encephale

Volumn 25, Issue SPEC. ISS. III, 1999, Pages 52-60

  Olie, J P ^a   Ghaoui, S ^b   Bayle, F J ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Antipsychotics; Atypical neuroleptics; Mood disorders; Schizophrenia; Side effects

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE;

AFFECTIVE NEUROSIS; AKATHISIA; ARTICLE; DRUG EFFICACY; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; HUMAN; PARKINSONISM; PSYCHOSIS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIBENZOTHIAZEPINES; HUMANS; IMIDAZOLES; INDOLES; PIPERAZINES; PIRENZEPINE; PSYCHOTIC DISORDERS; RISPERIDONE; SULPIRIDE; THIAZOLES;

EID: 0032731099     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. BAKER R, AMES D, UMBRICH D et al. Olanzapine's impact on depressive and obsessive compulsive symptoms in schizophrenia. Psychopharmacology Bull 1995 ; 31 : 549.
2. BANOV MD, ZARATE CA Jr, TOHEN M et al. Clozapine therapy in refractory affective disorders polarity predicts response in long-term follow-up. J Clin Psychiatry 1994 ; 55 : 295-300.
3. BONDOLFI G, BAUMANN P, PATRIS M et al. A randomized double-blind study of risperidone versus clozapine for treatment resistant chronic schizophrenia. APA, 148th., Annual Meeting, New Research Program and Abstract 1995 : 185.
4. BONUCELLI U, CERAVALLO R et al. Clozapine in Huntington's chorea. Neurology 1994 ; 44 : 821-3.
5. BOYER P, LECRUBIER Y, PUECH AJ et al. Treatment of negative symptoms in schizophrenia with amisulpride. Br J Psychiatry 1995 ; 166 : 68-72.
6. BREIER A. Mechanism of action of clozapine. J Clin Psychiatr Monograph 1996 ; 14 : 6-7.
7. BROWN GL, LINNOILA MK. CSF serotonin metabolite (5HIAA) studies in depression, impulsivity and violence, J Clin Psychiatry 1990 ; 51 : 31-41.
8. CALABRESE JR, KIMMEL SE, WOYSHVILL MJ et al. Clozapine for treatment refractory mania. Am J Psychiatry 1996 ; 153 : 759-64.
9. CHOUINARD G. Effects of risperidone in tardive dyskinesia : An analysis of the Canadian multicenter risperidone study. J Clin Psychopharmacol 1995 ; 16 (Suppl 1) : 365-445.
10. CHOUINARD G, JONES BN, REMINGTON G et al. A Canadian multicenter placebo controlled study of fixed dose of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1997 ; 13 : 35-40.
11. CHOW EWC, BURY A, ROY S et al. The effect of clozapine on agression (abstract). New York : Abstracts of the 149 th. annual meeting of the American Psychiatric Association, 1996 : 170.
12. CRAWFORD AM, BEASLEY Jr CM, TOLLEFSON GD. Olanzapine impact of an atypical antipsychotic candidate on prolactin release. APA annual Meeting New York New research program and abstract, 1996 : 268.
13. DAVIS JM, JANICAK PG. Meta-analysis of treatment outcome with risperidone versus conventional neuroleptics. APA annual Meeting New York : New research program and abstract, 1996 : 171.
14. DENIKER P, GINESTET D. Les effets psychiques des neuroleptiques. Confront Psychiatr 1975 ; 13 : 135-53.
15. DENIKER P, LOO H, ZARIFIAN E et al. Un nouveau médicament psychotrope : la carpipramine, composé de transition entre deux classes thérapeutiques. Encephale 1977 ; III : 13-148.
16. EMSLEY RA, Mc EARLY R, LEMMES P. Risperidone in the treatment of first episode patients with schizophrenic disorder : a double-blind multicenter comparison with haloperidol. APA annual Meeting New York : New research program and abstract, 1995 : 180.
17. FRAZER JA, GORDON CT, Mc KENNAK et al. An open trial of clozapine in 11 adolescents with childhood onset schizophrenia. J Am Acad Child and Adolescent Psychiatry 1994 ; 33 : 658-63.
18. FRIEDMAN JH, LANNON MC. Clozapine in the treatment of psychosis, Parkinson's disease. Neurology 1989 ; 39 (9) : 1219-21.
19. GINESTET D. Effets antipsychotiques des neuroleptiques. In : Colonna L, Petit M, Lepine JP eds. Dictionnaire des neuroleptiques. Paris : JB Baillière, 1989 : 41-9.
20. HAGGER C, BUCKLEY P, KENNY JT et al. Improvement in cognitive function and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psyhiatry 1993 ; 34 : 702-12.
21. HIPPIUS H. The history of clozapine. Psychopharmacology 1989 ; 99 : S3-5.
22. HIRSCH SR. Seroquel : an exemple of atypical antipsychotic drug. Neuropsychopharmacology 1994 ; 10 (Suppl 3) : 3615.
23. HIRSCHFELD RMA. Schizo-affective disorder and psychotic mania. Psychiatric Annuals 1996 ; 26 : S435-9.
24. HONIGFELD G. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis. Psychiatric Services 1996 ; 47 : 52-6.
25. JAFFE E, TREMEAU F, SHARIF Z et al. Clozapine in tardive Tourette's syndrome. Biol Psychiatry 38 : 196-7.
26. KANE J, HOMIGFELD HG, SINGER J, MELTZER H. Clozapine for the treatment resistant schizophrenia : a double blind comparison with chlorpromazine. Arch Gen Psychiatry 1988 ; 45 : 789-96.
27. KHAN BV, GLAZER WM. Risperidone for severely distributed behavior and tardive dyskinesia in developmental disabled adults. New Research Poster. New York : APA Annual Meeting, 1996 : 176.
28. LEE HS, KWON Y, ALPHA LP. Effect of clozapine on psychogenic polydipsia in chronic schizophrenic. J Clin Psychopharmacol 1991 ; 11 (3) : 222-3.
29. LEWANDER T, WESTERBERGER SE, ORGEN SO et al. Remoxipride, a selective dopamine D2 receptor antagonist in acute treatment of schizophrenia. Encephale 1990 ; XVI : 153-17.
30. LIEBERMAN JA, SAFFERMAN AZ. Clinical profile of clozapine : adverse reactions and agranulocytosis. Psychiatr Quarterly 1992 ; 63:51-70.
31. LIEBMAN JM, GERHARDT SC, GERBER R. Effects of 5-HTIA agonists and 5-HT2 antagonists on haloperidol-induced dyskinesia in squirrel Monkeys : no evidence for reciprocal 5-HT-DA interaction. Psychopharmacology 1989 ; 97 : 456-61.
32. LINAZAROSO G, MASSO J et al. Nocturnal akathisia in Parkinson's disease, treatment with clozapine. Mouvements Disorders 1993 ; 8 : 171-4.
33. LINDENMAYER JP, PARK M, ISKANDER A et al. A clozapine versus risperidone in treatment refractory state psychiatric inpatients. APA, 148 th., Annual Meeting, New Research Program and Abstract, 1996 : 231.
34. LOO H, POIRIER-LITTRE MF, THERON M et al. Amisulpride versus placebo in the long treatment of the negative symptoms of schizophrenia. Br J Psychiatry 1997 ; 170 : 18-22.
35. MARDER SR, MEIBACH RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994 ; 151 (6) : 825-35.
36. MELTZER HY. The neuroendocrine profile of clozapine, an atypical antipsychotic agent. J Clin Psychiatry 1990 ; 8 : 15-21.
37. PAILLERE-MARTINOT ML, LECRUBIER Y, MARTINOT JL et al. Improvement of some schizophrenia deficit symptoms with low dose of amisulpride. Am J Psychiatry 1995 ; 152 : 130-3.
38. PEUSKENS J, CARMAN J, VAUGENENGDEN A. Risperidone in the treatment of negative symptoms of schizophrenia : a meta-analysis. Clin Psychopharmacol 1995 ; 10 (4) : 207-13.
39. PICKAR D, OWEN R, LITHMAN RE et al. Clinical and biological response to clozapine in patients with schizophrenia : crossover comparison with fluphenazine. Arch Gen Psychiatry 1992 ; 49 : 345-53.
40. REVICKI D, GENDUSO LA, HAMILTON SL et al. Quality of life outcomes for olanzapine and haloperidol treatment for schizophrenia and related psychotic disorders. APA annual Meeting New York : New research program and abstract, 1996, p. 184. - Suppes T, Mc Elroy S, Gilbert J et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992 ; 32 : 270-80.
41. REVICKI D, GENDUSO LA, HAMILTON SL et al. Quality of life outcomes for olanzapine and haloperidol treatment for schizophrenia and related psychotic disorders. APA annual Meeting New York : New research program and abstract, 1996, p. 184. - Suppes T, Mc Elroy S, Gilbert J et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992 ; 32 : 270-80.
42. SAUGER T, LEBERMAN J, TOHEN M et al. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry 1999 ; 1 : 156.
43. SUPPES T, RUSH JA, WEBB A et al. One year randomized trial of clozapine vs usual care in bipolar I patients. Biol Psychiatry 1996 ; 39 : 531.
44. SUPPES T, Mc ELROY S, GILBERT J et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992 ; 32 : 270-80.
45. TOHEN M, SANGER T, TOLLEFSON GD et al. Olanzapine vs haloperidol in the treatment of schizo-affective bipolar patients. In : New Research Program and abtsracts of the annual meeting of the APA, 1997: 206 p.
46. TOLLEFSON GD, BEASLEY CM et al. Olanzapine versus haloperidol : results of the multicenter, international trial. Schizoph Res 1996 ; 18 : 131.
47. TRAN PV. Clinical efficacy and safety of olanzapine, new atypical antipsychotic agent. Philadelphia : APA meeting, 1994.
48. ZARATE CA Jr, TOHEN M, BALDESSARINI RJ. Clozapine in severe mood disorders. J Clin Psychiat 1995 ; 56 : 411-7.
49. ZIMBROFF DL, MACK RJ, ZBOROWSKI J et al. The efficacy and safety of three doses of sertindole versus three doses of haloperidol in schizophrenic patients. APA annual Meeting New York : New research program and abstract, 1996 : 218.